Lachlan Brown

Stock Analyst at William Blair

(2.37)
# 2,575
Out of 5,134 analysts
11
Total ratings
55.56%
Success rate
11.72%
Average return

Stocks Rated by Lachlan Brown

Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $28.29
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270$200
Current: $141.63
Upside: +41.21%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $50.54
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $8.27
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $6.99
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $421.95
Upside: +42.20%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $283.46
Upside: +23.47%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $21.57
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $65.22
Upside: +37.99%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $60.06
Upside: +266.30%